Higher cross-subtype IFN-γ ELISpot responses to Gag and Nef peptides in Brazilian HIV-1 subtype B- and F1- than in C-infected subjects-Reference-Cited by-同舟云学术

Higher cross-subtype IFN-γ ELISpot responses to Gag and Nef peptides in Brazilian HIV-1 subtype B- and F1- than in C-infected subjects

Published:2013-02 Issue:7 Volume:31 Page:1106-1112
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Côrtes Fernanda Heloise,Bello Gonzalo,Vorsatz Carla,Pilotto José Henrique,Guimarães Monick Lindenmeyer,Grinsztejn Beatriz,Veloso Valdiléa Gonçalves,Pinto Aguinaldo Roberto,Morgado Mariza Gonçalves

Funder

Department of STD, AIDS and Viral Hepatitis/Brazilian Ministry of Health

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference48 articles.

1. Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review;Girard;Vaccine,2011

2. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand;Rerks-Ngarm;N Engl J Med,2009

3. Viral evolution and escape during acute HIV-1 infection;Boutwell;J Infect Dis,2010

4. Prospects for an AIDS vaccine: three big questions, no easy answers;Garber;Lancet Infect Dis,2004

5. Evolutionary and immunological implications of contemporary HIV-1 variation;Korber;Br Med Bull,2001

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Next-generation sequencing analyses of the emergence and maintenance of mutations in CTL epitopes in HIV controllers with differential viremia control;Retrovirology;2018-09-10

2. Cross-Neutralizing Antibodies in HIV-1 Individuals Infected by Subtypes B, F1, C or the B/Bbr Variant in Relation to the Genetics and Biochemical Characteristics of the env Gene;PLOS ONE;2016-12-09

3. HIV Controllers With Different Viral Load Cutoff Levels Have Distinct Virologic and Immunologic Profiles;JAIDS Journal of Acquired Immune Deficiency Syndromes;2015-04-01

4. Challenges in the Design of a T Cell Vaccine in the Context of HIV-1 Diversity;Viruses;2014-10-23

5. Group M consensus Gag and Nef peptides are as efficient at detecting clade A1 and D cross-subtype T-cell functions as subtype-specific consensus peptides;Vaccine;2014-06